Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLF vs GSK✓SelectedUSD · GSKCLF vs GSK performance historyLatest closeAs of+0.08%11/18
Stock and ETF performance explorer

CLF vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+67.9%
GSK return
+101.2%
Excess return
-33.3%
Maximum drawdown
-82.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-1.3%+1.4%+0.6%
7D-10.4%-3.1%-7.2%-9.2%
30D-16.5%-0.9%-15.6%-16.5%
3M-0.8%-4.2%+3.3%0.0%
6M+10.5%-1.6%+12.1%+9.7%
YTD-11.3%+2.6%-13.9%-14.1%
1Y+5.3%+6.2%-0.9%+0.3%
3Y-30.7%+55.0%-85.6%-48.7%
5Y-45.2%+42.8%-88.0%-58.4%
10Y+67.9%+102.1%-34.2%+16.5%
All+67.9%+101.2%-33.3%+16.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling